Dr. Ahmad Bahlool
Lecturer
Biography:
Dr. Bahlool obtained his BSc of Pharmacy from the University of Jordan. He then completed a joint Master’s degree in Nanomedicine for Drug Delivery through Erasmus Mundus joint Master’s program Jointly between four universities Université Paris Cité and the University of Angers in France, the University of Pavia in Italy, and the University of Patras in Greece. He was then awarded his PhD in Translational pharmaceutics from the Royal College of Surgeons in Ireland (RCSI), where his doctoral research focused on the development of inhalable nanoparticle-based host-directed immunotherapies for
Tuberculosis.
Following completion of his PhD, Dr. Bahlool gained international industry experience as a Process Development Scientist at CureVac SE, contributing to the development and scale-up of GMP- compliant mRNA vaccine formulations. He served as Assistant Professor of pharmaceutical sciences at the school of pharmacy at Al-Zaytoonah
University of Jordan. Currently, Dr. Bahlool is a lecturer in Pharmacy at the School of Pharmacy and Biomolecular Sciences at Royal College of Surgeons in Ireland (RCSI), and the International College for Pharmaceutical Innovation (ICPI) , SUDA, Suzhou, China.
Research interests:
Inhalable and pulmonary therapeutics
Host-directed immunotherapy for infectious diseases
RNA-based therapeutics and mRNA vaccine technologies
Cancer nanomedicine
Long acting injectables development
